Hologic, Inc. (HOLX) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $76.01. It has a SharesGrow Score of 57/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of HOLX = $104.62 (+37.6% from the current price, the stock appears undervalued). Analyst consensus target is HOLX = $78 (+2.3% upside).
Valuation: HOLX trades at a trailing Price-to-Earnings (P/E) of 31.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.59.
Financials: revenue is $4.1B, -5.1%/yr average growth. Net income is $566M, growing at -6.7%/yr. Net profit margin is 13.8% (healthy). Gross margin is 61% (-0.6 pp trend).
Balance sheet: total debt is $2.6B against $5.0B equity (Debt-to-Equity (D/E) ratio 0.52, moderate). Current ratio is 3.75 (strong liquidity). Debt-to-assets is 29.1%. Total assets: $9.0B.
Analyst outlook: 18 / 42 analysts rate HOLX as buy (43%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 35/100 (Fail), Growth 15/100 (Fail), Past 100/100 (Pass), Health 83/100 (Pass), Moat 76/100 (Pass), Future 34/100 (Fail), Income 55/100 (Partial).
